Heide Götze1, Jochen Ernst1, Elmar Brähler1,2, Georg Romer3, Kai von Klitzing4. 1. Department of Medical Psychology and Medical Sociology, University of Leipzig, Leipzig, Germany. 2. Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Mainz, Mainz, Germany. 3. Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Münster, Münster, Germany. 4. Department of Child and Adolescent Psychiatry, Psychotherapy and Psychosomatics, University Medical Center Leipzig, Leipzig, Germany.
Abstract
OBJECTIVE: The objective of this study is to assess the quality of life (QOL) of cancer patients and their family members over 1-year period post therapy. METHODS: We evaluated QOL in cancer patients (N = 161) (Short Form-8 Health Survey (SF-8), European Organization for Research and Treatment of Cancer 30- Item Core Quality of Life Questionnaire (EORTC QLQ-C30)), their partners (N = 110) (SF-8), and their children (N = 115) (KIDSCREEN-27) using a longitudinal design (t1: post therapy, t2: 6 months after t1, t3: 12 months after t1). Multiple regression models were employed to examine factors related to QOL. RESULTS: After cancer therapy, impairments in the patients' QOL were found primarily in emotional and social areas and also in role functions. We found the highest symptom burden in fatigue (M = 45.21), sleep disturbances (M = 41.04), and financial difficulties (M = 39.2). Partners had lower mental QOL compared with the general population at each assessment point (p < 0.05). No significant difference was found in physical QOL between partners and the general population (p > 0.05). Social support, full-time employment, tumor stage 0-2, time since diagnosis <1 year, and lower levels of anxiety and depression were associated with better QOL in patients. Full-time employment, social support, and lower levels of anxiety and depression had a significant impact on the partners' QOL. Higher levels of anxiety and depression in patients (p = 0.006) adversely influenced children's QOL. CONCLUSIONS: Family members' QOL is overall stable over time indicating the need for professional psychosocial support for those family members with low QOL. For the children, new measures are needed to better examine the experience with parental cancer.
OBJECTIVE: The objective of this study is to assess the quality of life (QOL) of cancerpatients and their family members over 1-year period post therapy. METHODS: We evaluated QOL in cancerpatients (N = 161) (Short Form-8 Health Survey (SF-8), European Organization for Research and Treatment of Cancer 30- Item Core Quality of Life Questionnaire (EORTC QLQ-C30)), their partners (N = 110) (SF-8), and their children (N = 115) (KIDSCREEN-27) using a longitudinal design (t1: post therapy, t2: 6 months after t1, t3: 12 months after t1). Multiple regression models were employed to examine factors related to QOL. RESULTS: After cancer therapy, impairments in the patients' QOL were found primarily in emotional and social areas and also in role functions. We found the highest symptom burden in fatigue (M = 45.21), sleep disturbances (M = 41.04), and financial difficulties (M = 39.2). Partners had lower mental QOL compared with the general population at each assessment point (p < 0.05). No significant difference was found in physical QOL between partners and the general population (p > 0.05). Social support, full-time employment, tumor stage 0-2, time since diagnosis <1 year, and lower levels of anxiety and depression were associated with better QOL in patients. Full-time employment, social support, and lower levels of anxiety and depression had a significant impact on the partners' QOL. Higher levels of anxiety and depression in patients (p = 0.006) adversely influenced children's QOL. CONCLUSIONS: Family members' QOL is overall stable over time indicating the need for professional psychosocial support for those family members with low QOL. For the children, new measures are needed to better examine the experience with parental cancer.
Authors: Nik Nairan Abdullah; Idayu Badilla Idris; Khadijah Shamsuddin; Nik Muhd Aslan Abdullah Journal: Support Care Cancer Date: 2019-07-29 Impact factor: 3.603
Authors: Nancy A Borstelmann; Tamryn F Gray; Shari Gelber; Shoshana Rosenberg; Yue Zheng; Meghan Meyer; Kathryn J Ruddy; Lidia Schapira; Steven Come; Virginia Borges; Tamara Cadet; Peter Maramaldi; Ann H Partridge Journal: Support Care Cancer Date: 2022-01-28 Impact factor: 3.603
Authors: Heide Götze; Michael Friedrich; Elmar Brähler; Georg Romer; Anja Mehnert; Jochen Ernst Journal: Support Care Cancer Date: 2016-09-13 Impact factor: 3.603
Authors: Lesley Stafford; Michelle Sinclair; Jane Turner; Louise Newman; Claire Wakefield; Mei Krishnasamy; G Bruce Mann; Leslie Gilham; Kylie Mason; Paula Rauch; Julia Cannell; Penelope Schofield Journal: Pilot Feasibility Stud Date: 2017-12-11
Authors: Harper G Hubbeling; Shoshana M Rosenberg; Maria Cecilia González-Robledo; Julia G Cohn; Cynthia Villarreal-Garza; Ann H Partridge; Felicia M Knaul Journal: PLoS One Date: 2018-05-22 Impact factor: 3.240
Authors: Jade Pilato; Géraldine Dorard; Basilie Chevrier; Agnes Leu; Aurélie Untas Journal: Int J Environ Res Public Health Date: 2022-06-27 Impact factor: 4.614